ADVANCES IN CANCER IMMUNOTHERAPY: CURRENT TRENDS AND FUTURE DIRECTIONS

Authors

  • Dr. John m. Walker Division of Cancer Immunology, Massachusetts General Hospital, Boston, USA. Author

DOI:

https://doi.org/10.71465/bhsr30

Keywords:

Cancer Immunotherapy, Immuno-Oncology, Checkpoint Inhibitors, CAR-T Cell Therapy, Tumor Microenvironment

Abstract

Cancer immunotherapy has emerged as one of the most promising approaches in cancer these therapies, their clinical applications, and the challenges associated with their use, treatment, offering new avenues for targeting malignancies that were previously deemed difficult to treat. This paper provides a comprehensive overview of the current trends in cancer immunotherapy, highlighting the advancements in immune checkpoint inhibitors, adoptive cell therapies, and cancer vaccines. We discuss the mechanisms underlying including immune-related adverse events and patient response variability. Additionally, the paper explores future directions in cancer immunotherapy, focusing on combination therapies, personalized medicine, and the integration of novel technologies such as artificial intelligence in optimizing therapeutic outcomes. By reviewing the latest clinical trials and emerging strategies, this article aims to provide an updated perspective on the evolving field of cancer immunotherapy.

image

Downloads

Published

2022-12-31

Issue

Vol. 3 No. 02 (2022): Bulletin of Health Services Research

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

All articles published in the Bulletin of Health Services Research are open access and distributed under the terms of the Creative Commons Attribution License. This permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Authors retain copyright, and the journal ensures free and permanent access to published content.